Publication Listing for the MeSH term Intensity-Modulated Radiotherapy. Found 20 abstracts

Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet (London, England). 2019 Jan 05;393(10166):40-50.   PMCID: PMC6541928

Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2018 Jan;41(1):59-64.   PMCID: PMC4769977

Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, Badiozamani KR, Lawton CA, Horwitz EM, Michalski JM, Roof K, Beyer DC, Zhang Q, Sandler HM. Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621. Cancer. 2017 Jul;123(13):2489-96.   PMCID: PMC5474197

Deng J, Feng Y, Ma C, Yin FF. Novel Technologies for Improved Treatment Outcome and Patient Safety in Cancer Radiotherapy. Biomed Res Int. 2016 Jan;2016:3016454.   PMCID: PMC4791494

Dai X, Zhao Y, Liang Z, Dassarath M, Wang L, Jin L, Chen L, Dong J, Price RA, Ma CM. Volumetric-modulated arc therapy for oropharyngeal carcinoma: a dosimetric and delivery efficiency comparison with static-field IMRT. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB). 2015 Feb;31(1):54-9.   PMCID: PMC4282814

Martin JM, Handorf EA, Price RA, Cherian G, Buyyounouski MK, Chen DY, Kutikov A, Johnson ME, Ma CC, Horwitz EM. Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer. Medical Dosimetry. 2015 Jan;40(3):186-9.   PMCID: 4500753

Murphy CT, Heller S, Ruth K, Buyyounouski MK, Weinberg D, Uzzo RG, Plimack E, Kutikov A, Chen DY, Horwitz EM. Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques. Practical radiation oncology. 2015 May;5(3):e215-e222.   PMCID: Needs PMCID

Tong X, Chen XM, Li JS, Xu QQ, Lin MH, Chen LL, Price RA, Ma CM. Intrafractional prostate motion during external beam radiotherapy monitored by a real-time target localization system. J Appl Clin Med Phys. 2015 Mar 08;16(2):51-61.

Dyer MA, Arvold ND, Chen YH, Pinnell NE, Mitin T, Lee EQ, Hodi FS, Ibrahim N, Weiss SE, Kelly PJ, Floyd SR, Mahadevan A, Alexander BM. The role of whole brain radiation therapy in the management of melanoma brain metastases. Radiat Oncol. 2014 Jun;9:143.   PMCID: 4132230

Vazquez Quino LA, Chen X, Fitzpatrick M, Shi C, Stathakis S, Gutierrez A, Esquivel C, Mavroidis P, Alkhatib H, Papanikolaou N. Patient specific pre-treatment QA verification using an EPID approach. Technol Cancer Res Treat. 2014 Feb;13(1):1-10.   PMCID: *

Yang B, Wei XD, Zhao YT, Ma CM. Dosimetric evaluation of integrated IMRT treatment of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2014 Jan;39(2):185-9.   PMCID: No NIH funding

Yang B, Wei XD, Zhao YT, Ma CM. Dosimetric evaluation of integrated IMRT treatment of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy. Med Dosim. 2014 Jan;39(2):185-9.

Turaka A, Parsons RB, Buyyounouski MK. Radiation therapy for pituitary metastasis: report of four cases. Tumori. 2012 Jan;98(1):e1-6.   PMCID: Not NIH funded

Turaka A, Li T, Nicolaou N, Lango MN, Burtness B, Horwitz EM, Ridge JA, Feigenberg SJ. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer. Int J Radiat Oncol Biol Phys. 2011 Jan;79(1):65-70.   PMCID: PMC3339153

Freedman GM, Li T, Nicolaou N, Chen Y, Ma CC, Anderson PR. Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys. 2009 Jul;74(3):689-94.   PMCID: PMC2720600

Eade TN, Horwitz EM, Ruth K, Buyyounouski MK, D'Ambrosio DJ, Feigenberg SJ, Chen DY, Pollack A. A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant. Int J Radiat Oncol Biol Phys. 2008 Jun;71(2):338-45.

Lin T, Chen Y, Hossain M, Li J, Ma CM. Dosimetric investigation of high dose rate, gated IMRT. Med Phys. 2008 Nov;35(11):5079-87.

Luo W, Li J, Fourkal E, Fan J, Xu X, Chen Z, Jin L, Price R, Ma CM. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams. Phys Med Biol. 2008 Dec 21;53(24):7151-66.

Freedman GM, Anderson PR, Goldstein LJ, Ma CM, Li J, Swaby RF, Litwin S, Watkins-Bruner D, Sigurdson ER, Morrow M. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys. 2007 Mar 20;68(2):347-53.

Konski A, Watkins-Bruner D, Feigenberg S, Hanlon A, Kulkarni S, Beck JR, Horwitz EM, Pollack A. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Aug;66(2):408-15.

The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Intensity-Modulated Radiotherapy radiotherapy methods Aged Male Middle Aged pathology Female adverse effects Adult Radiotherapy Dosage 80 and over Aged Prostatic Neoplasms therapeutic use Computer-Assisted Radiotherapy Planning Retrospective Studies surgery therapy Neoplasm Staging Antineoplastic Agents Treatment Outcome Breast Neoplasms etiology complications Radiation Dosage Radiometry Follow-Up Studies drug therapy mortality Dose Fractionation Time Factors Imrt instrumentation Neoplasms Radiotherapy radiation effects Disease-Free Survival Conformal Radiotherapy Intensity-modulated radiation therapy secondary Prostate-Specific Antigen Movement Thoracic Wall administration & dosage Lymph Node Excision Drug Administration Schedule Brachytherapy Modified Radical Mastectomy Dosimetry Kaplan-Meier Estimate Radiation Injuries Volumetric-modulated arc therapy Chemoradiotherapy Oropharyngeal Neoplasms blood Multivariate Analysis Acute Disease Adjuvant Chemoradiotherapy Carcinoma Non-Small-Cell Lung Carcinoma Young Adult physiopathology Adenocarcinoma Breast cancer Prognosis Androgen Antagonists Photons Squamous Cell Carcinoma Linear Models Squamous Cell Carcinoma of Head and Neck Cancer Care Facilities Physiologic Monitoring Ductal Carcinoma-Breast Segmental Mastectomy Prostate cancer Radiation Dose-Response Relationship diagnostic imaging Radiation Absorption X-Ray Computed Tomography Lung Neoplasms Gastrointestinal Tract Testis Organs at Risk utilization Kallikreins Melanoma Nitriles Skin Neoplasms Headache Prostate anatomy & Cetuximab Survival Analysis Reproducibility of Results Computer Systems androgen deprivation Fatal Outcome Iodine Radioisotopes high risk radiation analogs & derivatives Neoplasm Invasiveness Vmat Imaging Phantoms Cisplatin Tosyl Compounds Gonadotropin-Releasing Hormone Monte Carlo Method Radiation Exposure Patient Selection Oropharyngeal carcinoma Four-Dimensional Computed Tomography Radiation Protection Radiodermatitis Organ Size diagnosis Patient Safety docetaxel Magnetic Resonance Imaging Proportional Hazards Models Pancreatic Neoplasms Taxoids Incidence Prostatectomy Gastrointestinal Diseases Anilides postprostatectomy Health Care Costs histology Inflammatory Breast Neoplasms chemotherapy Intraductal Carcinoma-Noninfiltrating Smoking Neoplasm Grading Palliative Care Risk Assessment Tissue Distribution Confusion Gastrostomy Decision Support Techniques Lasers Survival Rate Urogenital System Deoxycytidine Organ Sparing Treatments Brain Neoplasms economics Quality-Adjusted Life Years Treatment Failure Disease Management